However, it is not only ineffective for RA but also an anti-IL-5 agent that sometimes develops arthritis by reducing the concomitant glucocorticoid dose.[12] Similarly, anti-IgE antibodies can also reduce glucocorticoid doses, but their effects are limited to cases with high IgE levels.[13]. Here, IL5 is linked to rheumatoid arthritis.